Extracellular matrix remodelling and cellular differentiation

Current Opinion in Cell Biology

Volumn 11, Issue 5, 1999, Pages 634-640

  Streuli, Charles ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GROWTH FACTOR; MATRIX METALLOPROTEINASE; SCLEROPROTEIN;

CELL DIFFERENTIATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW; TISSUE REPAIR; TRANSCRIPTION REGULATION;

EID: 0032842777     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)00026-5     Document Type: Review

References (65)

1. •].
2. Howe A, Aplin AE, Alahari SK, Juliano RL Integrin signaling and cell growth control. Curr Opin Cell Biol. 10:1998;220-231. These two reviews are essential reading for those interested in crosstalk between growth factor and extracellular matrix signalling. They are both excellent.
3. •].
4. •].
5. •] show that both the prolactin-stimulated Jak/Stat pathway and the insulin-triggered IRS-1/PI 3-kinase signalling cascade are exquisitely sensitive to cell-matrix interactions. They complement extensive literature showing that extracellular matrix profoundly affects Ras-Erk signalling and proliferation.
6. Hay ED An overview of epitheliomesenchymal transformation. Acta Anafornica. 154:1995;6-20.
7. Werb Z ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:1997;439-442.
8. Rudolph Owen LA, Matrisian LM Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. J Mam Gland Biol Neoplasia. 3:1998;177-189.
9. Shapiro SD Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 10:1998;602-608. This review covers what has been learnt recently from targeted deletions of MMP genes.
10. Nagase H, Woessner JF Matrix metalloproteinases. J Biol Chem. 274:1999;21491-21494. An excellent review covering the latest in mechanisms that regulate MMP expression and activity.
11. •].
12. •] elegantly use transgenic mice to show that ECM remodelling enzymes are expressed at sites of cellular differentiation during embryonic development.
13. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:1998;411-422. A very well written paper about the role in vivo of ECM remodelling through MMP-9.
14. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science. 275:1997;1787-1790.
15. Takeuchi N, Ichikawa Y, Ishikawa T, Momiyama N, Hasegawa S, Nagashima Y, Miyazaki K, Koshikawa N, Mitsuhashi M, Shimada H Matrilysin gene expression in sporadic and familial colorectal adenomas. Mol Carcinogen. 19:1997;225-229.
16. Crawford HC, Fingleton BM, Rudolph Owen LA, Goss KJH, Rubinfeld B, Polakis P, Matrisian LM The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 18:1999;2883-2891. A matrix remodelling enzyme was one of the first genes to be identified as a target for β-catenin regulation.
17. Wilson CL, Heppner KJ, Labosky PA, Hogan BLM, Matrisian LM Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA. 94:1997;1402-1407.
18. •] are excellent and very readable reviews focusing on MMP function. Both are essential reading.
19. Martin P Wound healing - aiming for perfect skin regeneration. Science. 276:1997;75-81.
20. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol. 137:1997;1445-1457.
21. Pilcher BK, Dumin J, Schwartz MJ, Mast BA, Schultz GS, Parks WC, Welgus HG Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J Biol Chem. 274:1999;10372-10381. A nice series of papers from this group, including [20], describe remodelling events that occur during epidermal wound healing.
22. 1 integrin-mediated cell adhesion. J Cell Sci. 111:1998;1127-1135. Exposure of cryptic sites within ECM molecules during remodelling can have profound effects on cell behaviour.
23. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM, Welgus HG, Parks WC Matrilysin expression and function in airway epithelium. J Clin Invest. 102:1998;1321-1331.
24. Borradori L, Sonnenberg A Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Derm. 112:1997;411-418.
25. Goldfinger LE, Stack MS, Jones JCR Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol. 141:1998;255-265. Laminin-directed cell behaviour is profoundly affected by remodelling enzymes.
26. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med. 2:1996;287-292.
27. Giannelli G, Falk Marzillier J, Schiraldi O, Stetler Stevenson WG, Quaranta V Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 277:1997;225-228.
28. Giannelli G, Pozzi A, Stetler Stevenson WG, Gardner HA, Quaranta V Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am J Path. 154:1999;1193-1201.
29. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougler JP, Gray JW, Pinkel D, Bissell MJ, Werb Z The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98:1999;137-146. Direct evidence that the ECM remodelling enzyme, MMP-3, can promote neoplasis in vivo.
30. Thomasset N, Lochter A, Sympson CJ, Lund LR, Williams DR, Behrendtsen O, Werb Z, Bissell MJ Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Path. 153:1998;457-467.
31. Sieweke MH, Thompson NL, Sporn MB, Bissell MJ Mediation of wound-related Rous-Sarcoma Virus tumorigenesis by TGF-β Science. 248:1990;1656-1660.
32. Montgomery AMP, Reisfeld RA, Cheresh DA Integrin-α(V)β(3) rescues melanoma-cells from apoptosis in 3-dimensional dermal collagen. Proc Natl Acad Sci USA. 91:1994;8856-8860.
33. •].
34. Zhong CL, Chrzanowska Wodnicka M, Brown J, Shaub A, Belkin AM, Burridge K Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol. 141:1998;539-551. A novel aspect of ECM remodelling is that individual ECM molecules can be stretched, thereby altering the way that cells perceive them.
35. Garcia AJ, Vega MD, Boettiger D Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell. 10:1999;785-798.
36. Masson R, Lefebvre O, Noel A, Fahime ME, Chenard MP, Wendling C, Kebers F, LeMeur M, Dierich A, Foidart JMet al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol. 140:1998;1535-1541.
37. Jones JI, Gockerman A, Busby WH, Camachohubner C, Clemmons DR Extracellular-matrix contains insulin-like growth-factor binding protein-5 - potentiation of the effects of IGF-I. J Cell Biol. 121:1993;679-687.
38. Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF Dual role for the latent transforming growth-factor-β binding-protein in storage of latent TGF-β in the extracellular-matrix and as a structural matrix protein. J Cell Biol. 131:1995;539-549.
39. Parker A, Gockerman A, Busby WH, Clemmons DR Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth-muscle cells. Endocrinology. 136:1995;2470-2476.
40. Imai Y, Busby WH, Smith CE, Clarke JB, Garmong AJ, Horwitz GD, Rees C, Clemmons DR Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. J Clin Invest. 100:1997;2596-2605.
41. Jung JN, Zheng MH, Goldfarb M, Zaret KS Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science. 284:1999;1998-2003.
42. Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, Rudikoff S, Agronson SA, Varmus HE, Rubin JS Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA. 94:1997;6770-6775.
43. Marques G, Musacchio M, Shimell MJ, Wunnenberg Stapleton K, Cho KW, O'Connor MB Production of a DPP activity gradient in the early Drosophila embryo through the opposing actions of the SOG and TLD proteins. Cell. 91:1997;417-426.
44. Piccolo S, Agius E, Lu B, Goodman S, Dale L, De Robertis EM Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell. 91:1997;407-416.
45. Zhu Y, Oganesian A, Keene DR, Sandell LJ Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-β 1 and BMP-2. J Cell Biol. 144:1999;1069-1080. Growth factors that regulate cell fate bind to ECM proteins. Together with [43,44], the implication is that ECM has a direct role in regulating developmental decisions.
46. Prockop DJ, Sieron AL, Li SW Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol. 16:1998;399-408.
47. Black RA, White JM ADAMs: focus on the protease domain. Curr Opin Cell Biol. 10:1998;654-659.
48. Kuno K, Terashima Y, Matsushima K ADAMTS-1 is an active metalloproteinase associated extracellular matrix. J Biol Chem. 274:1999;18821-18826.
49. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins. Science. 284:1999;1664-1666.
50. Qi HL, Rand MD, Wu XH, Sestan N, Wang WY, Rakic P, Xu T, Artavanis-Tsakonas S Processing of the Notch ligand delta by the metalloprotease kuzbanian. Science. 283:1999;91-94.
51. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Jonhson RS, Fitzner JN An essential role for ectodomain shedding in mammalian development. Science. 282:1998;1281-1284.
52. Dong JY, Opresko LK, Dempsey PJ, Lauffenburger DA, Coffey RJ, Wiley HS Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc Natl Acad Sci USA. 96:1999;6235-6240.
53. Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 92:1998;391-400.
54. •].
55. Griscelli F, Li H, Bennaceur-Griscelli A, Soria J, Opolon P, Soria C, Perricaudet M, Yeh P, Lu H Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA. 95:1998;6367-6372.
56. Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M, Folkman J Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA. 95:1998;5579-5583.
57. •].
58. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.
59. Ramchandran R, Dhanabal M, Volk R, Waterman MJF, Segal M, Lu H, Knebelmann B, Sukhatme VP Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun. 255:1999;735-739.
60. •] demonstrate that ECM-derived peptides resulting from matrix remodelling have dramatic effects on cellular behaviour.
61. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812.
62. Levi E, Fridman R, Miao HQ, Ma YS, Yayon A, Vlodavsky I Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA. 93:1996;7069-7074.
63. Barasch J, Yang J, Qiao JZ, Tempst P, Erdjument-Bromage H, Leung W, Oliver JA Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest. 103:1999;1299-1307. A role for ECM remodelling enzymes in kidney development.
64. Martin DC, Fowlkes JL, Babic B, Khokha R Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. J Cell Biol. 148:1999;881-882. Fascinating story about how the balance between MMP and TIMP in a liver model regulates the bioavailability of free insulin-like growth factor (IGF)-II through IGFBP-3 proteolysis, and thereby IGF-I receptor signalling and hepatocellular carcinoma.
65. Lefebvre O, Sorokin L, Kedinger M, SimonAasmann P Developmental expression and cellular origin of the laminin alpha 2, alpha 5 and alpha 5 chains in the intestine. Dev Biol. 210:1998;135-150.